ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 26.31.
Share Price | ₹4,874.4 | Jun 09,2025 |
Market Cap | ₹58,297.8 Cr | |
Earnings-TTM | ₹2,216.0 Cr | TTM-Consolidated Results |
Price/Earnings | 26.31x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹58,297.8 Cr] as on Jun 09,2025
(/) Earnings [ ₹2,216.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 26.31x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 26.31 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 29.21x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.28x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALKEM LABORATORIES | 2,216.00 | 26.31 | 58,297.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.02 | 406,519.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.28 | 175,903.0 |
CIPLA LTD | 5,291.05 | 23.00 | 121,669.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 56.31 | 107,605.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.30 | 110,097.0 |
MANKIND PHARMA LTD | 2,003.22 | 48.54 | 97,239.7 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.23 | 97,951.9 |
LUPIN LTD | 3,306.26 | 27.54 | 91,051.4 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.19 | 67,457.2 |
ABBOTT INDIA LTD | 1,414.44 | 47.79 | 67,600.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.19x |
Max industry PE | 80.28x |
Median industry PE | 27.54x |
Average industry PE | 36.96x |
You may also like the below Video Courses